Version 1
: Received: 26 October 2023 / Approved: 27 October 2023 / Online: 27 October 2023 (10:26:21 CEST)
How to cite:
Hasnain, S. Z. U.; Ahmed, M.; Alzahrani, A. Y.; Khan, M. A.; Wazir, M. A.; Abbas, K. Phytochemical and Biological Investigations of Ficus carica L. Leaf Extract Along with Formulation Development. Preprints2023, 2023101773. https://doi.org/10.20944/preprints202310.1773.v1
Hasnain, S. Z. U.; Ahmed, M.; Alzahrani, A. Y.; Khan, M. A.; Wazir, M. A.; Abbas, K. Phytochemical and Biological Investigations of Ficus carica L. Leaf Extract Along with Formulation Development. Preprints 2023, 2023101773. https://doi.org/10.20944/preprints202310.1773.v1
Hasnain, S. Z. U.; Ahmed, M.; Alzahrani, A. Y.; Khan, M. A.; Wazir, M. A.; Abbas, K. Phytochemical and Biological Investigations of Ficus carica L. Leaf Extract Along with Formulation Development. Preprints2023, 2023101773. https://doi.org/10.20944/preprints202310.1773.v1
APA Style
Hasnain, S. Z. U., Ahmed, M., Alzahrani, A. Y., Khan, M. A., Wazir, M. A., & Abbas, K. (2023). Phytochemical and Biological Investigations of <em>Ficus carica</em> L. Leaf Extract Along with Formulation Development. Preprints. https://doi.org/10.20944/preprints202310.1773.v1
Chicago/Turabian Style
Hasnain, S. Z. U., M asif Wazir and Khizar Abbas. 2023 "Phytochemical and Biological Investigations of <em>Ficus carica</em> L. Leaf Extract Along with Formulation Development" Preprints. https://doi.org/10.20944/preprints202310.1773.v1
Abstract
Utilization of medicine derived from plants has been documented in various traditional systems of medicines throughout the world for different diseases. Therefore, the current research work was carried out to evaluate the phytochemical and biological potential of Ficus carica L ethanolic leaf extract. For this purpose, physicochemical and phytochemical analysis, total phenolic and flavonoids contents was performed. Antioxidant potential was determined by FRAP, DPPH and H2O2 assay. Proteinase inhibition, heat induced hemolysis and BSA denaturation assay was carried out for inflammation. Antiglycation potential was assessed by fructosamine assay, Congo-red assay and estimation of free carbonyl groups. In-vivo antidiabetic, anti-obesity, effect on liver and kidney were investigated by high fat high sugar diet model. FTIR, HPLC and LCMS/MS analysis was performed to find out the compounds. Tablet based formulation was developed using wet granulation method and tested for physicochemical parameters. Results shows that total phenolic and flavonoids content was (333 mg GAE/g) and (123 mg RE/g) respectively, H2O2 assay shows 35.6% free radical inhibition potential, DPPH assay shows (IC50) inhibitory concentration at 0.58 mg/mL, and 88.769 µg/g Fe2SO4 solution FRAP values. Proteinase inhibition assay, Heat induced hemolysis and BSA-denaturation assay shows percentage inhibition of 28 ± 0.01, 55 ± 0.03 and 51.2 ± 0.05 respectively. In Antiglycation activity β-amyloid formation assay shows absorption of 0.017, Fructosamine assay shows inhibition of 19.4±0.06 and free carbonyl group estimation shows inhibition of 17.0±0.03. In in-vivo study FLE at (500 mg/kg) significantly decreased total bilirubin (p ≤ 0.001), decreased (p ≤ 0.05) alanine transferase, aspartate aminotransferase, alkaline phosphatase, decreased blood glucose, triglycerides and total cholesterol (p ≤ 0.01) while HDL (p ≤ 0.01) was significantly increased in comparison to obesity and diabetic-obesity groups. Different functional groups presence was confirmed by FTIR spectrum. HPLC analysis revealed the existence of ferulic acid, rutin, chlorogenic acid, coumarin and thymoquinone and these results are corelated by LC-MS/MS. Pre-compression characterization showed angle of repose (33.04°), bulk density (0.54 g/cm3), tapped density (0.73 g/cm3), compressibility index (35.179 %) and Hausner’s ratio (1.35), while the post-compression characterization showed weight variation 826±4.17 mg, thickness 10.50±0.25 kg/cm2, friability 0.57 %, and disintegration time 8.19 min. From the above results it is concluded that F. carica L. leaves extract has strong antioxidant, antidiabetic and hypolipidemic potential and can be used for an obesity and diabetes treatment.
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.